Skip to main content
. 2019 Oct 28;20:391. doi: 10.1186/s12882-019-1549-x

Fig. 1.

Fig. 1

Evaluation of urinary cf-nDNA and urine cf-mtDNA as predictors of CKD patient outcomes after 6 months. The areas under the curves (AUC) were as follows: urine cf-mtDNA: 0.685 (0.586–0.784, P = 0.001*), and urine cf-nDNA: 0.730 (0.637–0.823, P < 0.001*)